Skip to main content
. Author manuscript; available in PMC: 2015 Jun 2.
Published in final edited form as: Gynecol Oncol. 2009 Jun;113(3):327–330. doi: 10.1016/j.ygyno.2009.02.018

Fig. 1.

Fig. 1

Kaplan–Meier curve for overall survival (N = 24). Median survival was 18.5 months (range 1.8–50.7 months) for patients treated with weekly topotecan and docetaxel. The median time to best response was 2.5 months (range 1.1–6 months).